Peter S. Kirlin - Dec 30, 2021 Form 4 Insider Report for PHOTRONICS INC (PLAB)

Signature
/s/Richelle E. Burr, attorney-in-fact for Peter S. Kirlin
Stock symbol
PLAB
Transactions as of
Dec 30, 2021
Transactions value $
-$600,101
Form type
4
Date filed
1/6/2022, 09:21 AM
Previous filing
Dec 10, 2021
Next filing
Jan 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PLAB Common Stock Options Exercise $3.41K +300 +0.08% $11.35 400K Dec 30, 2021 Direct
transaction PLAB Common Stock Sale -$5.81K -300 -0.08% $19.36 400K Dec 30, 2021 Direct F1, F2, F3
transaction PLAB Common Stock Options Exercise $27.6K +2.43K +0.61% $11.35 402K Dec 30, 2021 Direct
transaction PLAB Common Stock Sale -$47.1K -2.43K -0.61% $19.35 400K Dec 30, 2021 Direct F1, F2, F3
transaction PLAB Common Stock Options Exercise $32.3K +3.75K +0.94% $8.60 403K Jan 3, 2022 Direct
transaction PLAB Common Stock Sale -$71.2K -3.75K -0.93% $18.98 400K Jan 3, 2022 Direct F1, F3
transaction PLAB Common Stock Tax liability -$164K -8.69K -2.17% $18.85 391K Jan 3, 2022 Direct F4
transaction PLAB Common Stock Tax liability -$190K -9.85K -2.52% $19.28 381K Jan 3, 2022 Direct F5
transaction PLAB Common Stock Tax liability -$186K -9.85K -2.58% $18.85 371K Jan 3, 2022 Direct F6
transaction PLAB Common Stock Award $0 +90K +24.24% $0.00 461K Jan 3, 2022 Direct F7

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PLAB Stock Options (Right to Buy) Options Exercise $0 -300 -4.17% $0.00 6.89K Dec 30, 2021 Common Stock 300 $11.35 Direct
transaction PLAB Non-Qualified Stock Options Options Exercise $0 -2.43K -11.29% $0.00 19.1K Dec 30, 2021 Common Stock 2.43K $11.35 Direct
transaction PLAB Stock Options (Right to Buy) Options Exercise $0 -3.75K -100% $0.00* 0 Jan 3, 2022 Common Stock 3.75K $8.60 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by Dr. Kirlin.
F2 This transaction was executed in multiple trades. The price reported above reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and the prices at which the transaction was effected.
F3 Net proceeds of sale to offset a tax liability from restricted stock vesting and to fund children's education.
F4 Shares withheld to meet tax liabilities associated with Restricted Stock Awards granted on January 2, 2019.
F5 Shares withheld to meet tax liabilities associated with Restricted Stock Awards granted on January 3, 2020.
F6 Shares withheld to meet tax liabilities associated with Restricted Stock Awards granted on January 2, 2021.
F7 25% of the Restricted Stock Awards granted will vest on each anniversary date of the grant over 4 years.